Latest filing published 15 Jun 2023 for Alector, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Tillman U. Gerngross: trading record in brief
Tillman U. Gerngross, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Alector, Inc., X4 Pharmaceuticals, Inc and Invivyd, Inc. In total, 7 filings cover trades dated from 20 November 2017 to 14 June 2023.
Purchases make up the whole of the open-market record (1 purchase, €1.7M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants.
The newest entry dates from 15 June 2023: a share grant, in Alector, Inc. The most recent open-market purchase was published on 20 November 2017, 3,276 days ago. Most trades are made public on the day they happen. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Tillman U. Gerngross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 26,250 shares0Common StockSEC:0000950170-23-028275:0
- 9,459 shares0Common StockSEC:0001209191-22-038538:0
- 25,860,700 sharesCommon StockSEC:0001209191-21-051296:0
3 of 3 declarations
